| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 1.99e-06 | 5 | 118 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 3.21e-05 | 11 | 118 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | NEDD8 activating enzyme activity | 3.46e-05 | 2 | 118 | 2 | GO:0019781 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 5.96e-05 | 363 | 118 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 6.98e-05 | 14 | 118 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 3.18e-04 | 446 | 118 | 10 | GO:0004674 |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 3.27e-04 | 23 | 118 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 3.42e-04 | 5 | 118 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 3.42e-04 | 5 | 118 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 4.74e-04 | 26 | 118 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 6.57e-04 | 29 | 118 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB31 RAB22A RAB1C KIF12 ABCA10 RHOU TUFM NLRP3 GSPT1 RAB10 RAB21 HSPA2 ABCC10 | 6.69e-04 | 775 | 118 | 13 | GO:0017111 |
| GeneOntologyMolecularFunction | thioredoxin-disulfide reductase (NADPH) activity | 7.13e-04 | 7 | 118 | 2 | GO:0004791 | |
| GeneOntologyMolecularFunction | translation termination factor activity | 7.13e-04 | 7 | 118 | 2 | GO:0008079 | |
| GeneOntologyMolecularFunction | translation release factor activity | 7.13e-04 | 7 | 118 | 2 | GO:0003747 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 9.47e-04 | 8 | 118 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 9.47e-04 | 8 | 118 | 2 | GO:0004972 | |
| GeneOntologyMolecularFunction | GTPase activity | 9.57e-04 | 341 | 118 | 8 | GO:0003924 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 9.64e-04 | 33 | 118 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | protein-disulfide reductase (NAD(P)H) activity | 1.21e-03 | 9 | 118 | 2 | GO:0047134 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | STK36 POLD1 STK32B STK32C STK35 STK32A POLR3B LATS1 LATS2 CSNK1G1 POLI NT5C2 AKT1 PKN3 | 1.28e-03 | 938 | 118 | 14 | GO:0016772 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB31 RAB22A RAB1C KIF12 ABCA10 RHOU TUFM NLRP3 GSPT1 RAB10 RAB21 HSPA2 ABCC10 | 1.38e-03 | 839 | 118 | 13 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB31 RAB22A RAB1C KIF12 ABCA10 RHOU TUFM NLRP3 GSPT1 RAB10 RAB21 HSPA2 ABCC10 | 1.39e-03 | 840 | 118 | 13 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB31 RAB22A RAB1C KIF12 ABCA10 RHOU TUFM NLRP3 GSPT1 RAB10 RAB21 HSPA2 ABCC10 | 1.39e-03 | 840 | 118 | 13 | GO:0016818 |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.51e-03 | 10 | 118 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 1.51e-03 | 10 | 118 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.57e-03 | 39 | 118 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.82e-03 | 41 | 118 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.84e-03 | 11 | 118 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 2.16e-03 | 224 | 118 | 6 | GO:0016741 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor | 2.20e-03 | 12 | 118 | 2 | GO:0016668 | |
| GeneOntologyMolecularFunction | GTP binding | 2.49e-03 | 397 | 118 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | protein kinase activity | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 2.97e-03 | 600 | 118 | 10 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 NT5C2 AKT1 PKN3 | 3.21e-03 | 709 | 118 | 11 | GO:0016773 |
| GeneOntologyMolecularFunction | GDP binding | 3.27e-03 | 103 | 118 | 4 | GO:0019003 | |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 3.50e-03 | 105 | 118 | 4 | GO:0008170 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 3.58e-03 | 172 | 118 | 5 | GO:0008757 | |
| GeneOntologyMolecularFunction | 3'-5'-DNA exonuclease activity | 3.94e-03 | 16 | 118 | 2 | GO:0008296 | |
| GeneOntologyMolecularFunction | FMN binding | 3.94e-03 | 16 | 118 | 2 | GO:0010181 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 4.44e-03 | 17 | 118 | 2 | GO:0004970 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 4.57e-03 | 439 | 118 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 4.57e-03 | 439 | 118 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on a sulfur group of donors | 4.67e-03 | 57 | 118 | 3 | GO:0016667 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 5.14e-03 | 59 | 118 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 5.14e-03 | 59 | 118 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | cadherin binding involved in cell-cell adhesion | 5.54e-03 | 19 | 118 | 2 | GO:0098641 | |
| GeneOntologyMolecularFunction | kinase activity | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 NT5C2 AKT1 PKN3 | 5.59e-03 | 764 | 118 | 11 | GO:0016301 |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 6.14e-03 | 20 | 118 | 2 | GO:0061608 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 1.72e-06 | 5 | 116 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 9.51e-06 | 8 | 116 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 2.66e-05 | 31 | 116 | 4 | GO:1901679 | |
| GeneOntologyBiologicalProcess | mitochondrial transmembrane transport | 3.00e-05 | 106 | 116 | 6 | GO:1990542 | |
| GeneOntologyBiologicalProcess | ADP transport | 3.67e-05 | 12 | 116 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | peptidyl-serine phosphorylation | 6.04e-05 | 307 | 116 | 9 | GO:0018105 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 7.42e-05 | 40 | 116 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 7.42e-05 | 40 | 116 | 4 | GO:0015868 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 7.51e-05 | 15 | 116 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | 8.10e-05 | 319 | 116 | 9 | GO:0018209 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 9.01e-05 | 42 | 116 | 4 | GO:0051503 | |
| GeneOntologyBiologicalProcess | inner cell mass cell fate commitment | 9.37e-05 | 3 | 116 | 2 | GO:0001827 | |
| GeneOntologyBiologicalProcess | inner cell mass cellular morphogenesis | 9.37e-05 | 3 | 116 | 2 | GO:0001828 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.08e-04 | 44 | 116 | 4 | GO:0015865 | |
| GeneOntologyBiologicalProcess | mammary gland epithelial cell differentiation | 1.57e-04 | 19 | 116 | 3 | GO:0060644 | |
| GeneOntologyBiologicalProcess | macromolecule methylation | 1.71e-04 | 145 | 116 | 6 | GO:0043414 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 1.79e-04 | 50 | 116 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | multicellular organismal locomotion | 1.87e-04 | 4 | 116 | 2 | GO:0071965 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 2.83e-04 | 23 | 116 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 2.83e-04 | 23 | 116 | 3 | GO:0015867 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 3.22e-04 | 24 | 116 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | methylation | 3.62e-04 | 234 | 116 | 7 | GO:0032259 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 4.10e-04 | 26 | 116 | 3 | GO:1905709 | |
| Domain | Aden_trnslctor | 2.49e-05 | 28 | 115 | 4 | IPR002113 | |
| Domain | Mit_carrier | 4.29e-05 | 32 | 115 | 4 | IPR002067 | |
| Domain | Mit_uncoupling | 4.80e-05 | 12 | 115 | 3 | IPR002030 | |
| Domain | Ser/Thr_kinase_AS | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 7.23e-05 | 357 | 115 | 10 | IPR008271 |
| Domain | S_TKc | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 7.57e-05 | 359 | 115 | 10 | SM00220 |
| Domain | Pkinase_C | 7.70e-05 | 37 | 115 | 4 | IPR017892 | |
| Domain | PROTEIN_KINASE_ST | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 8.11e-05 | 362 | 115 | 10 | PS00108 |
| Domain | Thioredoxin/glutathione_Rdtase | 1.12e-04 | 3 | 115 | 2 | IPR006338 | |
| Domain | Pkinase | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 1.24e-04 | 381 | 115 | 10 | PF00069 |
| Domain | Pkinase_C | 1.27e-04 | 42 | 115 | 4 | PF00433 | |
| Domain | SOLCAR | 3.16e-04 | 53 | 115 | 4 | PS50920 | |
| Domain | - | 3.16e-04 | 53 | 115 | 4 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 3.16e-04 | 53 | 115 | 4 | IPR018108 | |
| Domain | Mito_carr | 3.16e-04 | 53 | 115 | 4 | PF00153 | |
| Domain | Mt_carrier_dom | 3.16e-04 | 53 | 115 | 4 | IPR023395 | |
| Domain | LRR_6 | 3.65e-04 | 55 | 115 | 4 | PF13516 | |
| Domain | Pyr_OxRdtase_I_AS | 3.71e-04 | 5 | 115 | 2 | IPR012999 | |
| Domain | Pyr_redox_dim | 3.71e-04 | 5 | 115 | 2 | PF02852 | |
| Domain | PYRIDINE_REDOX_1 | 3.71e-04 | 5 | 115 | 2 | PS00076 | |
| Domain | AGC-kinase_C | 3.91e-04 | 56 | 115 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.91e-04 | 56 | 115 | 4 | PS51285 | |
| Domain | S_TK_X | 3.91e-04 | 56 | 115 | 4 | SM00133 | |
| Domain | PROTEIN_KINASE_ATP | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 5.44e-04 | 459 | 115 | 10 | PS00107 |
| Domain | Protein_kinase_ATP_BS | 5.63e-04 | 379 | 115 | 9 | IPR017441 | |
| Domain | UBA-like | 6.52e-04 | 64 | 115 | 4 | IPR009060 | |
| Domain | - | 7.74e-04 | 7 | 115 | 2 | 3.30.390.30 | |
| Domain | - | 8.80e-04 | 120 | 115 | 5 | 3.40.50.150 | |
| Domain | Prot_kinase_dom | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 8.85e-04 | 489 | 115 | 10 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 9.41e-04 | 493 | 115 | 10 | PS50011 |
| Domain | SAM-dependent_MTases | 9.48e-04 | 122 | 115 | 5 | IPR029063 | |
| Domain | Pyr_nucl-diS_OxRdtase_dimer | 1.03e-03 | 8 | 115 | 2 | IPR004099 | |
| Domain | Transl_elong_EFTu/EF1A_C | 1.03e-03 | 8 | 115 | 2 | IPR004160 | |
| Domain | FAD/NAD-linked_Rdtase_dimer | 1.03e-03 | 8 | 115 | 2 | IPR016156 | |
| Domain | GTP_EFTU_D3 | 1.03e-03 | 8 | 115 | 2 | PF03143 | |
| Domain | RAB | 1.07e-03 | 73 | 115 | 4 | PS51419 | |
| Domain | G_TR_CS | 1.32e-03 | 9 | 115 | 2 | IPR031157 | |
| Domain | Ras | 1.54e-03 | 136 | 115 | 5 | PF00071 | |
| Domain | ThiF_NAD_FAD-bd | 1.64e-03 | 10 | 115 | 2 | IPR000594 | |
| Domain | Transl_elong_EF1A/Init_IF2_C | 1.64e-03 | 10 | 115 | 2 | IPR009001 | |
| Domain | ThiF | 1.64e-03 | 10 | 115 | 2 | PF00899 | |
| Domain | Kinase-like_dom | STK36 STK32B STK32C STK35 STK32A LATS1 LATS2 CSNK1G1 AKT1 PKN3 | 1.91e-03 | 542 | 115 | 10 | IPR011009 |
| Domain | G_TR_1 | 2.80e-03 | 13 | 115 | 2 | PS00301 | |
| Domain | Small_GTPase | 3.12e-03 | 160 | 115 | 5 | IPR001806 | |
| Domain | HEAT | 3.21e-03 | 48 | 115 | 3 | PF02985 | |
| Domain | Annexin | 3.26e-03 | 14 | 115 | 2 | IPR001464 | |
| Domain | IMPORTIN_B_NT | 3.26e-03 | 14 | 115 | 2 | PS50166 | |
| Domain | IBN_N | 3.74e-03 | 15 | 115 | 2 | PF03810 | |
| Domain | Small_GTP-bd_dom | 3.75e-03 | 167 | 115 | 5 | IPR005225 | |
| Domain | IBN_N | 4.26e-03 | 16 | 115 | 2 | SM00913 | |
| Domain | Importin-beta_N | 4.81e-03 | 17 | 115 | 2 | IPR001494 | |
| Domain | - | 4.97e-03 | 56 | 115 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 5.23e-03 | 57 | 115 | 3 | IPR023753 | |
| Domain | Iontro_rcpt | 5.39e-03 | 18 | 115 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 5.39e-03 | 18 | 115 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 5.39e-03 | 18 | 115 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 5.39e-03 | 18 | 115 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 5.39e-03 | 18 | 115 | 2 | SM00918 | |
| Domain | EFTu-like_2 | 5.39e-03 | 18 | 115 | 2 | IPR004161 | |
| Domain | Lig_chan | 5.39e-03 | 18 | 115 | 2 | PF00060 | |
| Domain | PBPe | 5.39e-03 | 18 | 115 | 2 | SM00079 | |
| Domain | GTP_EFTU_D2 | 5.39e-03 | 18 | 115 | 2 | PF03144 | |
| Domain | G_TR_2 | 5.39e-03 | 18 | 115 | 2 | PS51722 | |
| Domain | HEAT | 5.49e-03 | 58 | 115 | 3 | IPR000357 | |
| Domain | TF_GTP-bd_dom | 6.00e-03 | 19 | 115 | 2 | IPR000795 | |
| Domain | Pyr_redox_2 | 6.00e-03 | 19 | 115 | 2 | PF07992 | |
| Domain | P-loop_NTPase | RAB31 RAB22A KIF12 ABCA10 RHOU TUFM NLRP3 GSPT1 RAB10 NLRP14 RAB21 ABCC10 | 6.02e-03 | 848 | 115 | 12 | IPR027417 |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 2.42e-08 | 15 | 88 | 5 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 6.79e-08 | 18 | 88 | 5 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 9.17e-08 | 19 | 88 | 5 | M47677 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 1.54e-06 | 91 | 88 | 7 | MM15518 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 8.73e-06 | 118 | 88 | 7 | MM15589 | |
| Pathway | REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS | 2.04e-05 | 90 | 88 | 6 | M27779 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 2.73e-05 | 10 | 88 | 3 | M47694 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 4.97e-05 | 12 | 88 | 3 | M27728 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 5.20e-05 | 65 | 88 | 5 | MM15511 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 13 | 88 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 13 | 88 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.43e-05 | 13 | 88 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 8.14e-05 | 14 | 88 | 3 | M47692 | |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 1.13e-04 | 122 | 88 | 6 | M27872 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.24e-04 | 16 | 88 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.79e-04 | 18 | 88 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.12e-04 | 19 | 88 | 3 | M47760 | |
| Pathway | PID_HEDGEHOG_GLI_PATHWAY | 2.24e-04 | 48 | 88 | 4 | M219 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.48e-04 | 20 | 88 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.88e-04 | 21 | 88 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.32e-04 | 22 | 88 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.32e-04 | 22 | 88 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.80e-04 | 23 | 88 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.80e-04 | 23 | 88 | 3 | M47676 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM | 3.81e-04 | 5 | 88 | 2 | M47667 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 3.81e-04 | 5 | 88 | 2 | MM15655 | |
| Pathway | PID_AR_PATHWAY | 5.64e-04 | 61 | 88 | 4 | M58 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM | 5.69e-04 | 6 | 88 | 2 | M47668 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | 7.18e-04 | 65 | 88 | 4 | M27771 | |
| Pathway | WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2 | 1.05e-03 | 8 | 88 | 2 | M39900 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E STK36 SIPA1L3 HECTD4 TASP1 GRIN2D STK32C TXNRD2 PTCH1 DYSF LATS2 TXNRD3 PDZD8 AKT1 ZNF324B TTC38 ARHGAP21 ABCC10 PKN3 | 7.24e-09 | 1105 | 119 | 19 | 35748872 |
| Pubmed | 3.91e-08 | 3 | 119 | 3 | 12450408 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 3.91e-08 | 3 | 119 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 3.91e-08 | 3 | 119 | 3 | 2829183 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PCBP3 GEMIN2 ANXA1 POLD1 TNPO2 GART SSB RCC2 TUFM GSPT1 AKR7A2 RAB10 PCYOX1L NAE1 PATJ RAB21 HSPA2 KPNB1 | 7.64e-08 | 1149 | 119 | 18 | 35446349 |
| Pubmed | 1.56e-07 | 4 | 119 | 3 | 33396658 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | CARM1 SLC25A4 SLC25A5 SLC25A6 POLD1 GART SSB TSPYL1 RCC2 TUFM GSPT1 WDR11 SLC25A1 EXD2 NAE1 SMARCB1 HSPA2 KPNB1 | 2.87e-07 | 1257 | 119 | 18 | 37317656 |
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 31474569 | ||
| Pubmed | Neurotransmission and bipolar disorder: a systematic family-based association study. | 3.89e-07 | 5 | 119 | 3 | 18444252 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 6.83e-07 | 210 | 119 | 8 | 26217791 | |
| Pubmed | 7.75e-07 | 6 | 119 | 3 | 10620603 | ||
| Pubmed | GEMIN2 INTS7 ARHGAP10 POLD1 SIPA1L3 RAB22A TASP1 WDR55 DENND2D TSPYL1 RCC2 TUFM RAB10 WDR11 SUPT6H SLC25A1 EXD2 METTL18 PATJ | 8.04e-07 | 1497 | 119 | 19 | 31527615 | |
| Pubmed | 1.35e-06 | 7 | 119 | 3 | 21370995 | ||
| Pubmed | 1.80e-06 | 239 | 119 | 8 | 23246001 | ||
| Pubmed | SLC25A4 PCDHGB6 SLC25A5 SLC25A6 SIPA1L3 RAB22A CEP128 TUFM GSPT1 RAB10 LATS1 LATS2 SLC25A1 ALAS2 RAB21 HSPA2 ARHGAP21 KPNB1 | 2.05e-06 | 1442 | 119 | 18 | 35575683 | |
| Pubmed | Cloning of Rab GTPases expressed in human skeletal muscle: studies in insulin-resistant subjects. | 2.16e-06 | 8 | 119 | 3 | 9918381 | |
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 27641616 | ||
| Pubmed | 2.16e-06 | 8 | 119 | 3 | 32289155 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | CARM1 COL6A1 PCBP3 SLC25A4 SLC25A5 UGT1A7 GART RAB1C ACSF2 TUFM AKR7A2 RAB10 MRC2 NT5C2 PDZD8 AKT1 RAB21 KPNB1 | 2.24e-06 | 1451 | 119 | 18 | 30550785 |
| Pubmed | CARM1 RNMT SLC25A4 SLC25A5 SLC25A6 GART SSB TSPYL1 RCC2 TUFM RAB10 WDR11 EXD2 NAE1 SMARCB1 HSPA2 KPNB1 | 3.12e-06 | 1335 | 119 | 17 | 29229926 | |
| Pubmed | 3.39e-06 | 183 | 119 | 7 | 36129980 | ||
| Pubmed | 3.51e-06 | 67 | 119 | 5 | 16226712 | ||
| Pubmed | Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners. | 3.78e-06 | 186 | 119 | 7 | 31540324 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RNMT SLC25A4 SLC25A5 SLC25A6 WDR7 HECTD4 USP9Y CWC22 RCC2 TUFM RAB10 SUPT6H SLC25A1 SMARCB1 KPNB1 | 4.55e-06 | 1082 | 119 | 15 | 38697112 |
| Pubmed | 5.02e-06 | 72 | 119 | 5 | 16923123 | ||
| Pubmed | 5.70e-06 | 198 | 119 | 7 | 24337577 | ||
| Pubmed | RNA binding proteins co-localize with small tau inclusions in tauopathy. | 6.26e-06 | 283 | 119 | 8 | 30068389 | |
| Pubmed | Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2. | 6.32e-06 | 11 | 119 | 3 | 28486106 | |
| Pubmed | 6.32e-06 | 11 | 119 | 3 | 9647694 | ||
| Pubmed | CARM1 SLC25A4 SLC25A5 SLC25A6 GART RCC2 TUFM SLC25A1 RAB21 KPNB1 | 6.83e-06 | 484 | 119 | 10 | 31995728 | |
| Pubmed | Family-wide characterization of the DENN domain Rab GDP-GTP exchange factors. | 7.89e-06 | 37 | 119 | 4 | 20937701 | |
| Pubmed | 8.40e-06 | 12 | 119 | 3 | 16120388 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | RNMT ANXA1 TNPO2 SSB CEP128 RCC2 RAB10 SLC25A1 SMARCB1 ARHGAP21 | 8.75e-06 | 498 | 119 | 10 | 36634849 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | COL6A1 ANXA1 RAB22A KIF12 DYSF AKR7A2 RAB10 PTGR1 SLC25A1 PATJ RAB21 QDPR HSPA2 KPNB1 | 1.04e-05 | 1016 | 119 | 14 | 19056867 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 1.07e-05 | 84 | 119 | 5 | 25670202 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25482410 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10887961 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 30671453 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32283822 | ||
| Pubmed | Akt phosphorylation of La regulates specific mRNA translation in glial progenitors. | 1.16e-05 | 2 | 119 | 2 | 18836485 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 32826458 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29730476 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 26842067 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 1.16e-05 | 2 | 119 | 2 | 14749836 | |
| Pubmed | N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability. | 1.16e-05 | 2 | 119 | 2 | 23230145 | |
| Pubmed | Role of Annexin A1 in NLRP3 Inflammasome Activation in Murine Neutrophils. | 1.16e-05 | 2 | 119 | 2 | 33440601 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19366212 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35863437 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29317596 | ||
| Pubmed | LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function. | 1.16e-05 | 2 | 119 | 2 | 31848340 | |
| Pubmed | Expression of LATS family proteins in ovarian tumors and its significance. | 1.16e-05 | 2 | 119 | 2 | 25841306 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 33766086 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24026096 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 12112115 | ||
| Pubmed | AKT Regulates NLRP3 Inflammasome Activation by Phosphorylating NLRP3 Serine 5. | 1.16e-05 | 2 | 119 | 2 | 32929041 | |
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 1.16e-05 | 2 | 119 | 2 | 10926541 | |
| Pubmed | Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer. | 1.16e-05 | 2 | 119 | 2 | 32423384 | |
| Pubmed | Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. | 1.16e-05 | 2 | 119 | 2 | 34060480 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29651654 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31110197 | ||
| Pubmed | Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. | 1.16e-05 | 2 | 119 | 2 | 17049657 | |
| Pubmed | Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance. | 1.16e-05 | 2 | 119 | 2 | 31268774 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 35057644 | ||
| Pubmed | The Hippo pathway regulates human megakaryocytic differentiation. | 1.16e-05 | 2 | 119 | 2 | 27786336 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 31786200 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27048932 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16556444 | ||
| Pubmed | Cell type-dependent function of LATS1/2 in cancer cell growth. | 1.16e-05 | 2 | 119 | 2 | 30531839 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2823266 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15746036 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 19799973 | ||
| Pubmed | LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control. | 1.16e-05 | 2 | 119 | 2 | 32015438 | |
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 1.16e-05 | 2 | 119 | 2 | 10974536 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 25044019 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23838801 | ||
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 1.16e-05 | 2 | 119 | 2 | 11756613 | |
| Pubmed | CARM1 SLC25A5 POLD1 GART SSB RCC2 TUFM GSPT1 SUPT6H HSPA2 KPNB1 | 1.28e-05 | 638 | 119 | 11 | 33239621 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 1.30e-05 | 149 | 119 | 6 | 26370502 | |
| Pubmed | SLC25A4 SLC25A5 SLC25A6 ANXA1 GART SSB CWC22 RCC2 RAB10 SMARCB1 RAB21 KPNB1 | 1.70e-05 | 786 | 119 | 12 | 29128334 | |
| Pubmed | 1.78e-05 | 327 | 119 | 8 | 34428256 | ||
| Pubmed | 1.85e-05 | 94 | 119 | 5 | 36584595 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | PCBP3 SLC25A5 SLC25A6 ANXA1 GART RAB1C RCC2 TUFM FAM111B RAB10 SLC25A1 HSPA2 KPNB1 | 2.33e-05 | 949 | 119 | 13 | 36574265 |
| Pubmed | 2.38e-05 | 99 | 119 | 5 | 34161765 | ||
| Pubmed | SLC25A6 TNPO2 TSPYL1 CWC22 TUFM PCYOX1L POLR3B WDR11 SUPT6H KPNB1 | 2.40e-05 | 560 | 119 | 10 | 35241646 | |
| Pubmed | SLC25A5 SLC25A6 POLD1 SIPA1L3 GART SSB RCC2 TUFM GSPT1 RAB10 LATS1 SLC25A1 TRAPPC10 PATJ KPNB1 | 2.42e-05 | 1247 | 119 | 15 | 27684187 | |
| Pubmed | The mitochondrial transporter family SLC25: identification, properties and physiopathology. | 3.35e-05 | 53 | 119 | 4 | 23266187 | |
| Pubmed | RNMT SLC25A4 SLC25A5 SLC25A6 ANXA1 GART RCC2 TUFM SLC25A1 RAB21 HSPA2 KPNB1 | 3.41e-05 | 844 | 119 | 12 | 25963833 | |
| Pubmed | Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. | 3.47e-05 | 3 | 119 | 2 | 15242771 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 14690597 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9718984 | ||
| Pubmed | A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway. | 3.47e-05 | 3 | 119 | 2 | 30308519 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 31685802 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 28503860 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 24012335 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 34319001 | ||
| Pubmed | Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. | 3.47e-05 | 3 | 119 | 2 | 11259642 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 26363008 | ||
| Pubmed | Conservation in the mechanism of Nedd8 activation by the human AppBp1-Uba3 heterodimer. | 3.47e-05 | 3 | 119 | 2 | 12740388 | |
| Pubmed | Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. | 3.47e-05 | 3 | 119 | 2 | 12646924 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 35487271 | ||
| Interaction | CHRM4 interactions | 1.81e-05 | 94 | 117 | 6 | int:CHRM4 | |
| Interaction | MAPT interactions | PCBP3 SLC25A4 SLC25A5 SLC25A6 WDR7 TNPO2 GART RAB22A USP9Y CEP128 TUFM GSPT1 RAB10 SLC25A1 NT5C2 AKT1 QDPR HSPA2 KPNB1 | 2.32e-05 | 1119 | 117 | 19 | int:MAPT |
| Interaction | FAF1 interactions | 2.54e-05 | 334 | 117 | 10 | int:FAF1 | |
| Interaction | MOB3B interactions | 3.04e-05 | 11 | 117 | 3 | int:MOB3B | |
| GeneFamily | RAB, member RAS oncogene GTPases | 9.43e-06 | 65 | 79 | 5 | 388 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 3.90e-04 | 7 | 79 | 2 | 1201 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 8.29e-04 | 10 | 79 | 2 | 100 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.76e-03 | 18 | 79 | 2 | 596 | |
| GeneFamily | PDZ domain containing | 4.43e-03 | 152 | 79 | 4 | 1220 | |
| GeneFamily | DNA polymerases | 4.49e-03 | 23 | 79 | 2 | 535 | |
| GeneFamily | Selenoproteins | 5.30e-03 | 25 | 79 | 2 | 890 | |
| GeneFamily | NLR family | 5.30e-03 | 25 | 79 | 2 | 666 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 5.30e-03 | 25 | 79 | 2 | 994 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.82e-07 | 176 | 119 | 7 | 867936a20f73f638055c19c8d88834aa2cc657cf | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.99e-07 | 186 | 119 | 7 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | Control-B_memory-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.79e-06 | 136 | 119 | 6 | 94f23bef50c0beb54ed39b1a4b340f7aec4e75cd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 187 | 119 | 6 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 187 | 119 | 6 | 52b5b38bef3cc06487cf42c6fb22fb33f0c7ce2b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-05 | 191 | 119 | 6 | f631749ef1f2270133664cf5eb4cf545a8482bd3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 196 | 119 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 197 | 119 | 6 | 02cc9d39afefa5e5b6f5d93f9adc3a20050b70dd | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-05 | 199 | 119 | 6 | 15d7b2479a1426dd8f38ef70225ce07f48f320b2 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 200 | 119 | 6 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.08e-05 | 124 | 119 | 5 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 76 | 119 | 4 | 98271aadf026a01bf933f8279d11a0413e47d549 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-05 | 152 | 119 | 5 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-05 | 152 | 119 | 5 | 4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.04e-05 | 160 | 119 | 5 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.11e-05 | 169 | 119 | 5 | 7d39da562373865876fe16f35649b68da30a0a3a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-05 | 169 | 119 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 9.37e-05 | 170 | 119 | 5 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 175 | 119 | 5 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 176 | 119 | 5 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 178 | 119 | 5 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | Somatosensory_Cortex_(S1)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 179 | 119 | 5 | 82348bf56a4525b2f485696cab5b2ea6e96c2f91 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.26e-04 | 181 | 119 | 5 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.32e-04 | 183 | 119 | 5 | 5377b4fbd8fdfe68933b4c0965aa9525f7f31591 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.36e-04 | 184 | 119 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.39e-04 | 185 | 119 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 186 | 119 | 5 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 186 | 119 | 5 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.43e-04 | 186 | 119 | 5 | d3509a579871ba6a8c4edd6137b28f271c9dbe70 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-erythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-04 | 100 | 119 | 4 | f305bc37f97617007b59bf06d288dd14c3c06e42 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.50e-04 | 188 | 119 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.54e-04 | 189 | 119 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 189 | 119 | 5 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.58e-04 | 190 | 119 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.58e-04 | 190 | 119 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.65e-04 | 192 | 119 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 193 | 119 | 5 | eff718664fe0aaf89050efd9cc7b6dfb1df46666 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 193 | 119 | 5 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.74e-04 | 194 | 119 | 5 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.78e-04 | 195 | 119 | 5 | c5d2d9f12fd893331c9de261af30607d845d4f6a | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 195 | 119 | 5 | eb96439b59914954f684c4bfd9e9a6dbd3201a20 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.78e-04 | 195 | 119 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 1.78e-04 | 195 | 119 | 5 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 196 | 119 | 5 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 196 | 119 | 5 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | control-immature_Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-04 | 196 | 119 | 5 | e34fd3e7a5b1c22a81fd3208e6d58bdb846d51c4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 196 | 119 | 5 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 196 | 119 | 5 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.86e-04 | 197 | 119 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 198 | 119 | 5 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.91e-04 | 198 | 119 | 5 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.91e-04 | 198 | 119 | 5 | 70e62d815b2a0aa5327ff94d6f4d503176e007b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 198 | 119 | 5 | 0de0c612a1f030debde28bfd6fbae3697e8b48de | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.91e-04 | 198 | 119 | 5 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.91e-04 | 198 | 119 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-04 | 198 | 119 | 5 | 51c220507bb05aa6338fec494b8ecf4902437708 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.95e-04 | 199 | 119 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|COVID-19_Severe / Disease condition and Cell class | 1.95e-04 | 199 | 119 | 5 | ffb2ef9b7006cbed0f43637af040719b9776cbd5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-04 | 199 | 119 | 5 | 571accef38f5b03a7e032495d5c6d25d27073428 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 199 | 119 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.95e-04 | 199 | 119 | 5 | 8e87ba32fcc1d45be73098e5baa6c9c6369b97df | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 199 | 119 | 5 | 6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-04 | 199 | 119 | 5 | 1aa99d21bf61b86df4a966dc47634044430aa39f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 199 | 119 | 5 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 199 | 119 | 5 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | COVID-19-kidney-PCT-S3-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.95e-04 | 199 | 119 | 5 | 3e6cfc3c0b2edce0d51db9de80e38f724e6c0cb8 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.95e-04 | 199 | 119 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 199 | 119 | 5 | 41f3f5df41a142240947d9a57a6a282cba0c7aaa | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 200 | 119 | 5 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 200 | 119 | 5 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 200 | 119 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.00e-04 | 200 | 119 | 5 | 5a3b04aaad9562636aa34750d6025e0fe0f9b2ba | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 2.00e-04 | 200 | 119 | 5 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 2.00e-04 | 200 | 119 | 5 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.00e-04 | 200 | 119 | 5 | ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 2.00e-04 | 200 | 119 | 5 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-04 | 200 | 119 | 5 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 200 | 119 | 5 | 6e3d1ae0ef84d3075afa40129a41169996462672 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 200 | 119 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 2.00e-04 | 200 | 119 | 5 | 0350e5ffd36033099b7e32a1fdd790fff99790dc | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 2.00e-04 | 200 | 119 | 5 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 200 | 119 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-04 | 200 | 119 | 5 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 200 | 119 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 200 | 119 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.00e-04 | 200 | 119 | 5 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.00e-04 | 200 | 119 | 5 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.00e-04 | 200 | 119 | 5 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| Drug | Clodronate | 1.36e-07 | 3 | 118 | 3 | DB00720 | |
| Drug | EAB 515 | 2.20e-07 | 11 | 118 | 4 | CID000159489 | |
| Drug | dehydroabietylamine | 5.41e-07 | 4 | 118 | 3 | ctd:C000600819 | |
| Drug | closantel | 4.68e-06 | 7 | 118 | 3 | ctd:C023342 | |
| Drug | ddTTP | 5.72e-06 | 86 | 118 | 6 | CID000065051 | |
| Drug | SDZ 220-581 | 7.46e-06 | 8 | 118 | 3 | CID000128019 | |
| Drug | AC1L4X2K | 1.59e-05 | 10 | 118 | 3 | CID000193824 | |
| Drug | Adenosine triphosphate | 2.50e-05 | 33 | 118 | 4 | DB00171 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 2.36e-07 | 4 | 116 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | free androgen index | RNMT ARHGAP10 UGT1A7 CYP26A1 DENND2D WDR11 ARHGAP21 MACIR ABCC10 PKN3 KPNB1 | 2.81e-07 | 374 | 116 | 11 | EFO_0007005 |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 1.08e-05 | 35 | 116 | 4 | DOID:700 (implicated_via_orthology) | |
| Disease | collagen alpha-1(VI) chain measurement | 1.53e-05 | 2 | 116 | 2 | EFO_0801487 | |
| Disease | ras-related protein Rab-22A measurement | 1.52e-04 | 5 | 116 | 2 | EFO_0802991 | |
| Disease | mean arterial pressure | 1.62e-04 | 499 | 116 | 9 | EFO_0006340 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 2.01e-04 | 29 | 116 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | CARM1 UGT1A7 CYP26A1 ABCA10 RAB10 CSNK1G1 RP1 RAB21 PKN3 KPNB1 | 2.95e-04 | 663 | 116 | 10 | EFO_0004615 |
| Disease | benign neoplasm (implicated_via_orthology) | 4.22e-04 | 8 | 116 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 4.74e-04 | 163 | 116 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | brain ischemia (is_implicated_in) | 6.75e-04 | 10 | 116 | 2 | DOID:2316 (is_implicated_in) | |
| Disease | response to ondansetron, QT interval | 8.23e-04 | 11 | 116 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | kidney cancer (implicated_via_orthology) | 8.23e-04 | 11 | 116 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | brain connectivity measurement | 1.05e-03 | 400 | 116 | 7 | EFO_0005210 | |
| Disease | myeloid white cell count | RNMT HECTD4 PPCDC TSPAN9 NLRP3 SLC25A1 CSNK1G1 POLI RP1 WIPF2 PKN3 | 1.19e-03 | 937 | 116 | 11 | EFO_0007988 |
| Disease | creatinine measurement, glomerular filtration rate | 1.19e-03 | 117 | 116 | 4 | EFO_0004518, EFO_0005208 | |
| Disease | chromosome 22q11.2 deletion syndrome, distal (implicated_via_orthology) | 1.35e-03 | 14 | 116 | 2 | DOID:0060413 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 1.35e-03 | 206 | 116 | 5 | C0152013 | |
| Disease | feeling emotionally hurt measurement | 1.41e-03 | 56 | 116 | 3 | EFO_0009599 | |
| Disease | Synostotic Posterior Plagiocephaly | 1.77e-03 | 16 | 116 | 2 | C1833340 | |
| Disease | Craniosynostosis, Type 1 | 1.77e-03 | 16 | 116 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.77e-03 | 16 | 116 | 2 | C0030044 | |
| Disease | Trigonocephaly | 1.77e-03 | 16 | 116 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.77e-03 | 16 | 116 | 2 | C0265534 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.77e-03 | 16 | 116 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.77e-03 | 16 | 116 | 2 | C2713443 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.77e-03 | 16 | 116 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.77e-03 | 16 | 116 | 2 | C1860819 | |
| Disease | Brachycephaly | 2.00e-03 | 17 | 116 | 2 | C0221356 | |
| Disease | Adenomatous Polyposis Coli | 2.00e-03 | 17 | 116 | 2 | C0032580 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 2.25e-03 | 18 | 116 | 2 | C0342384 | |
| Disease | Meningioma | 2.51e-03 | 19 | 116 | 2 | C0025286 | |
| Disease | colorectal adenoma (is_marker_for) | 2.78e-03 | 20 | 116 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | corneal hysteresis | 2.78e-03 | 20 | 116 | 2 | EFO_0010066 | |
| Disease | Craniosynostosis | 2.78e-03 | 20 | 116 | 2 | C0010278 | |
| Disease | skin hydration measurement | 3.06e-03 | 21 | 116 | 2 | EFO_0009586 | |
| Disease | neutrophil count | RNMT HECTD4 PPCDC TSPAN9 NLRP3 SLC25A1 CSNK1G1 POLI AKT1 RP1 FBXL20 WIPF2 PKN3 | 3.09e-03 | 1382 | 116 | 13 | EFO_0004833 |
| Disease | skin neoplasm | 3.13e-03 | 74 | 116 | 3 | EFO_0004198 | |
| Disease | Esophageal Neoplasms | 3.63e-03 | 78 | 116 | 3 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 3.63e-03 | 78 | 116 | 3 | C0546837 | |
| Disease | response to clopidogrel, cardiovascular event measurement | 3.67e-03 | 23 | 116 | 2 | EFO_0006919, GO_1903493 | |
| Disease | malignant astrocytoma (is_marker_for) | 3.67e-03 | 23 | 116 | 2 | DOID:3069 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GHIKITDFGLCKEGI | 286 | P31749 | |
| TDFGLCKEGIKDGAT | 291 | P31749 | |
| LLKVADAGCSVGLGK | 16 | O76042 | |
| GLGDCLVKITKSDGI | 156 | P12236 | |
| LGLGGGDCRVKIATK | 91 | O43488 | |
| SILGVIGKEIDAACK | 826 | Q6ZU80 | |
| SFCVKKGEVLGLLGH | 1226 | Q8WWZ4 | |
| CDLLGAKGKDILYIG | 336 | P49902 | |
| GLGDCLVKIYKSDGI | 156 | P05141 | |
| KAASGLLSIGLCKGD | 111 | Q96CM8 | |
| LVNLCTKEGVLLKGG | 261 | Q15389 | |
| CIIFLLGETVGGDKE | 216 | Q9NWX5 | |
| GADLGCKDRKGYGLL | 196 | Q8NB46 | |
| LSKGCFGLKLDRIGS | 106 | P23582 | |
| VGKLLGEEKVDAILC | 71 | P09417 | |
| GAKAKLCSLGFVKDI | 526 | Q8TE60 | |
| KLEGSKCKGQLLIFG | 96 | Q9P258 | |
| KLLLIGDSGVGKTCV | 11 | P61026 | |
| DCLFKLLLIGDSGVG | 6 | Q92928 | |
| KVVLLGEGCVGKTSL | 21 | Q9UL25 | |
| LKVCLLGDTGVGKSS | 6 | Q9UL26 | |
| LKVCLLGDTGVGKSS | 6 | Q13636 | |
| KGLRSGKLGEQCEAV | 31 | Q9NVH2 | |
| AKDGGGLSTQCKVII | 321 | Q9Y5F9 | |
| TKGDYEKILVALCGG | 331 | P04083 | |
| GKLGDGEVFFLKECT | 311 | A1A4S6 | |
| IVGKVGCGKSSLLAA | 631 | Q5T3U5 | |
| LLAKGGICFIGDLAS | 401 | Q4G0Z9 | |
| LEEKIGCLLKFSGDL | 226 | P05455 | |
| CLSLKEKKITEGSGG | 11 | P40205 | |
| KFCLGEKLCADGAVG | 146 | O14893 | |
| VKIKTLGIGAFGEVC | 706 | O95835 | |
| IKTLGIGAFGEVCLA | 671 | Q9NRM7 | |
| SGFLKVCGGKVLELF | 911 | Q15034 | |
| GGKLCFVDLAGSEKV | 256 | Q96FN5 | |
| VGKKIGCGNFGELRL | 46 | Q9HCP0 | |
| EVAIGFLKECGLKLT | 291 | Q9HCG8 | |
| KIVLDVGCGSGILSF | 186 | Q86X55 | |
| EDGIKGCGITFTLGK | 46 | Q7L5Y1 | |
| ILKVGVGCSEDASKL | 161 | Q9NVH0 | |
| LDKKGCAGGEKNVLI | 186 | P54652 | |
| SVEGGNKLVCSGLLK | 241 | Q8NBM8 | |
| TGEELLKLAQKCTGG | 66 | Q96GV9 | |
| FKLGGLICLGHVSLK | 721 | Q8NEN9 | |
| FKIFCLDGVKGDLLI | 46 | P40261 | |
| GLKKIGSLKVSCEEF | 226 | Q5H8C1 | |
| VKVDKCLLGGLGLGE | 236 | P55259 | |
| KLDLSCNKDLGGGFE | 286 | Q6UY01 | |
| SKKACLRGGGDLVSI | 406 | Q9UBG0 | |
| FAGKKVLDLGCGSGL | 186 | O95568 | |
| NCGGLKKAGLLVEDT | 766 | Q6NSJ5 | |
| TGTLERGILKKGDEC | 276 | P49411 | |
| VAALCALGGFKETIK | 1731 | Q9Y4D8 | |
| VVLGKLESGSICKGQ | 316 | P15170 | |
| KIDIISGTLGKAFGC | 381 | P22557 | |
| CGSLIGKGGSKIKEI | 141 | P57721 | |
| LKGGQILCDLTKTKG | 56 | Q9Y6W8 | |
| LALCDFDGDGKKELL | 166 | Q9BXC9 | |
| CAIKKGLEQLLVGGS | 131 | P12109 | |
| VLELILKGCGGDLVS | 266 | Q9NQL9 | |
| LKGCGGDLVSAVEVL | 271 | Q9NQL9 | |
| LKEEILLACEGGTGT | 116 | Q9GZN8 | |
| LIGDLCTAFGKDVLK | 821 | Q14974 | |
| KRDITVLDLGCGKGG | 196 | O43148 | |
| GGGLRSCVGKEFAKI | 436 | O43174 | |
| LKGETIEGALCKDGR | 216 | Q6SJ93 | |
| GIGYKTAKCLEALGI | 266 | Q9UNA4 | |
| CKTVLTGKVGGLLAF | 991 | P28340 | |
| CVAEEGEKKILAGKL | 1971 | O75923 | |
| GCFGLFSKILDEVEK | 161 | Q9H6A0 | |
| GFLKIADFGLCKEGI | 696 | Q6P5Z2 | |
| FGLLEICGVKGGETV | 131 | Q14914 | |
| IAKLKGCKVVGAVGS | 161 | Q14914 | |
| TKIAGLTGDNLCKEG | 976 | P56715 | |
| ALGDSGVAILCEKAK | 866 | Q96P20 | |
| GNTLGDKGIKLLCEG | 921 | Q96P20 | |
| IDGKAGLFLLGCVKN | 371 | P0CI25 | |
| LVKKIKGDGFQCSGV | 6 | Q9NQ03 | |
| CEKAFVAGLLLGKGC | 401 | Q15573 | |
| GLKALFLKGCTQLED | 196 | Q96IG2 | |
| VLKALALGAKCIFLG | 286 | Q9NYQ3 | |
| KNCGKFLVVGLLIFG | 96 | Q13635 | |
| EEFLSLIGEKVCLKG | 651 | O60292 | |
| EKFALKLCSELGLGG | 291 | Q12824 | |
| KLCSELGLGGEFVTT | 296 | Q12824 | |
| LRAIGKGSFGKVCIV | 26 | Q8WU08 | |
| DIKEFLCGGKGLDQL | 406 | O75570 | |
| ILLAKGGGIKLCDFG | 131 | Q9NRP7 | |
| LRAIGKGSFGKVCIV | 96 | Q86UX6 | |
| GLGDCIIKIFKSDGL | 156 | P12235 | |
| CVAKKLVCGDEGLGA | 166 | Q96CD2 | |
| KCVLVGDGAVGKTSL | 51 | Q7L0Q8 | |
| ICQSAGLDGLAKKFG | 526 | Q7KZ85 | |
| LLDTCKVLVIGAGGL | 66 | Q8TBC4 | |
| ILKVADFGLSKVCAG | 376 | Q8TDR2 | |
| IVELVKDCKGLGFSI | 686 | Q8NI35 | |
| LKKGVQGGEKALEIC | 121 | Q9H0U9 | |
| GLFGVLICHLLKKKG | 71 | Q8IUW5 | |
| IDGKEGLFLLGCIKN | 371 | P0CI26 | |
| KESGILVLGAIAEGC | 411 | O14787 | |
| DCGLQILKKEGLKAF | 261 | P53007 | |
| GKLIELLAGKAGVLD | 941 | Q9NW08 | |
| FGCEKGGANLIKELI | 1451 | O00507 | |
| CKVDLGGFAGLFDLK | 466 | P22102 | |
| SLGGIEGCLSKLKAA | 46 | Q5R3I4 | |
| KDGLIVETLTVGCKG | 61 | Q15326 | |
| TVCGVAKGGKEILLS | 166 | Q9NNW7 | |
| KLLLTASGDGCLGIF | 181 | Q9H6Y2 | |
| SLIADIGCGTGKYLK | 46 | Q9P272 | |
| SGGLSCAKEAAILGK | 166 | Q86VQ6 | |
| LRAIGKGSFGKVCIV | 26 | Q9NY57 | |
| GRGALLQDICKGTKL | 36 | Q8TF74 | |
| LKSLGYLCGLVSEKG | 396 | P48553 | |
| GKLAEGVQLLCLIDK | 1061 | Q9BZH6 | |
| CGGEDGLLKVLKLET | 31 | Q9P2L0 | |
| RTGLSEGDGDKLKAC | 6 | Q5T5U3 | |
| EEDIGKLKSCLTGFL | 451 | Q13564 | |
| LEGSLVKKKGLQECF | 1336 | Q9Y4E6 | |
| LLCEGQKGKLSAGRI | 146 | Q9H6P5 | |
| LLLTCGFAKAGKLLV | 16 | Q9HAW7 | |
| VTGFLGCLGAIKENK | 66 | O75954 | |
| VDCGKGFAKGAVLLS | 456 | Q6AW86 | |
| LKGSDIGDNGVKSLC | 736 | Q86W24 | |
| EGCKLVTIGSGKVFA | 741 | Q14957 | |
| EGCKLVTIGSGKVFA | 771 | O15399 |